Kala Pharmaceuticals (KALA) PT Lowered to $8 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Francois Brisebois lowered the price target on Kala Pharmaceuticals (NASDAQ: KALA) to $8.00 (from $9.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
